Sterling Global Strategies LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sterling Global Strategies LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$354,000
-99.9%
22,0000.0%1.97%
+20.6%
Q4 2018$321,860,000
+80365.0%
22,0000.0%1.63%
-6.0%
Q3 2018$400,000
+7.8%
22,0000.0%1.74%
-27.3%
Q2 2018$371,000
-13.9%
22,0000.0%2.39%
+18.5%
Q1 2018$431,000
-3.4%
22,0000.0%2.02%
+7.2%
Q4 2017$446,000
+16.8%
22,0000.0%1.88%
+20.7%
Q3 2017$382,000
+35.5%
22,0000.0%1.56%
+15.5%
Q2 2017$282,000
-1.1%
22,0000.0%1.35%
-2.0%
Q1 2017$285,000
+31.3%
22,0000.0%1.38%
+56.3%
Q4 2016$217,000
-18.4%
22,0000.0%0.88%
-10.4%
Q3 2016$266,000
+40.0%
22,0000.0%0.98%
+36.4%
Q2 2016$190,000
-8.7%
22,0000.0%0.72%
-32.0%
Q1 2016$208,000
-45.4%
22,0000.0%1.06%
-82.4%
Q4 2015$381,000
+29.2%
22,0000.0%6.04%
+271.2%
Q3 2015$295,000
+8.9%
22,000
+83.3%
1.63%
+78.1%
Q2 2015$271,000
+58.5%
12,0000.0%0.91%
+75.4%
Q1 2015$171,000
+47.4%
12,0000.0%0.52%
+727.0%
Q4 2014$116,00012,0000.06%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders